Your browser doesn't support javascript.
loading
Development of a High-Affinity Antibody against the Tumor-Specific and Hyperactive 611-p95HER2 Isoform.
Dorraji, Esmaeil; Borgen, Elin; Segura-Peña, Dario; Rawat, Puneet; Smorodina, Eva; Dunn, Claire; Greiff, Victor; Sekulic, Nikolina; Russnes, Hege; Kyte, Jon Amund.
Afiliação
  • Dorraji E; Department of Cancer Immunology, Institute for Cancer Research, Oslo University Hospital, 0379 Oslo, Norway.
  • Borgen E; Department of Pathology, Oslo University Hospital, 0379 Oslo, Norway.
  • Segura-Peña D; Centre for Molecular Medicine Norway (NCMM), Nordic EMBL Partnership, Faculty of Medicine, University of Oslo, 0318 Oslo, Norway.
  • Rawat P; Department of Immunology, University of Oslo and Oslo University Hospital, 0372 Oslo, Norway.
  • Smorodina E; Department of Immunology, University of Oslo and Oslo University Hospital, 0372 Oslo, Norway.
  • Dunn C; Department of Cancer Immunology, Institute for Cancer Research, Oslo University Hospital, 0379 Oslo, Norway.
  • Greiff V; Department of Immunology, University of Oslo and Oslo University Hospital, 0372 Oslo, Norway.
  • Sekulic N; Centre for Molecular Medicine Norway (NCMM), Nordic EMBL Partnership, Faculty of Medicine, University of Oslo, 0318 Oslo, Norway.
  • Russnes H; Department of Chemistry, University of Oslo, 0371 Oslo, Norway.
  • Kyte JA; Department of Pathology, Oslo University Hospital, 0379 Oslo, Norway.
Cancers (Basel) ; 14(19)2022 Oct 05.
Article em En | MEDLINE | ID: mdl-36230782

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Tipo de estudo: Prognostic_studies Idioma: En Revista: Cancers (Basel) Ano de publicação: 2022 Tipo de documento: Article País de afiliação: Noruega

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Tipo de estudo: Prognostic_studies Idioma: En Revista: Cancers (Basel) Ano de publicação: 2022 Tipo de documento: Article País de afiliação: Noruega